Salarius Pharmaceuticals
VerifiedAn oncology based biotechnology company.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
($3m) (Public information from Jun 2024)
Share price
$2.38 SLRX
Houston Texas (HQ)
| USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 313 % | 51 % | (65 %) | - | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (273 %) | (150 %) | (699 %) | - | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (200 %) | (140 %) | (694 %) | - | - | - | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 116 % | 132 % | 465 % | - | - | - | - |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | $0.0 | round |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
* | N/A | $6.0m | Private Placement VC |
| Total Funding | 000k | ||
Related Content
Recent News about Salarius Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.